THE KEEPS STUDY KEEPS will increase our knowledge about menopausal hormone therapy by helping scientific research determine if hormone therapy prevents or delays the onset of the number one killer of women, heart disease. Click here for more information on heart disease. News and Updates Papers about the Kronos Early Estrogen Prevention Study have been published in esteemed journals and presented at several national and international conventions. Click here to view publications on KEEPS. COMMON QUESTIONS Why is the study important to women? What does KEEPS entail? Can I participate in KEEPS? When will the study begin and when will participants be recruited? Are there risks or side effects? Will I be compensated for my participation?   KEEPS » Kronos Early Estrogen Prevention Study WHY KEEPS Does initiating MHT in women at the menopausal transition provide significant protection against the major cause of heart attacks, atherosclerosis? Get the facts now.   Kronos Longevity Research Institute 2390 E. Camelback Rd. Suite 440 Phoenix, AZ 85016 Toll-Free:  (866) 878-1221 Fax:  (602) 778-7490 KEEPS@KronosInstitute.org

Home  |  About Us  |  KEEPS  |  Why KEEPS  |  FAQ  |  Contact Us
Who We Are  |  Governance  |  Board of Directors  |  Mission  |  Staff  |  Principal Investigators Roster
Press Releases  |  What is KEEPS?  |  Why KEEPS?  |  Study Overview  |  KEEPS Planning Consortium  |  Cardiovascular Disease
Estrogen  |  Stroke  |  Fractures  |  KEEPS  |  Hormone Replacement Therapy  |  General Information Request

Copyright 2006 Early Estrogen Prevention Study.  All rights reserved.
[ Sponsored by Kronos Longevity Research Institute ]